CSHA-1, a series of ALEXTAR VC, LLC, has recently filed an amendment to its exempt offering of securities. This move is significant as it indicates a strategic adjustment in the company’s funding approach, which may influence its future operations and investment opportunities.
Background
CSHA-1 operates under the entity ALEXTAR VC, LLC. It is classified under the SIC description, though specific details were not provided in the filing. The company has been active in the securities market, with its recent filings indicating a focus on investment opportunities. The most recent filing was made on October 26, 2026, with a prior one on September 16, 2026.
What the Filing Says
The filing, identified as a Form D/A, includes items related to the Investment Company Act, specifically Section 3(c) and Section 3(c)(1). The amendment was accepted on the same day it was filed, reflecting the company’s timely response to its funding needs.
Impact
This amendment may affect investors and stakeholders who are involved with CSHA-1 and ALEXTAR VC, LLC. The changes in the offering could provide new opportunities for investment or adjustments in existing commitments.
What's Next
The filing does not say what happens next.
Company Information
CSHA-1, a series of ALEXTAR VC, LLC, is incorporated in Delaware and has a fiscal year that ends on December 31st. The company is registered under the Central Index Key (CIK) number 0002132860, and its Employer Identification Number (EIN) is 422043332.
Filing Details
The recent Form D/A filing was accepted on October 26, 2026, at 10:23:12 AM, indicating that the amendment was processed promptly. The filing also confirms that the effectiveness date of the amendment is the same as the filing date.
Contact Information
CSHA-1 has a mailing and business address located at 548 Market St, Suite 855, San Francisco, CA 94104. For inquiries, the company can be reached at the phone number 385-955-3424.
Missing Information
The filing does not provide specific details regarding the amount of securities being offered or the intended use of the proceeds from this offering. Additionally, it lacks information on the types of investors targeted and any specific risks associated with the investment.